Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families:: evidence for a founder effect

被引:31
作者
Laake, K
Telatar, M
Geitvik, GA
Hansen, RO
Heiberg, A
Andresen, AM
Gatti, R
Borresen-Dale, AL [1 ]
机构
[1] Norwegian Radium Hosp, Canc Res Inst, Dept Genet, N-0310 Oslo, Norway
[2] Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA
关键词
Ataxia-Telangiectasia; founder effect; ATM; DDGE;
D O I
10.1038/sj.ejhg.5200181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ATM gene is responsible for the autosomal recessive disorder Ataxia-Telangiectasia (AT). Many different mutations, located all across the gene, have been reported with a predominance of truncating mutations. By using PTT (protein truncation test) a mutation was found in one Norwegian AT family. Sequencing revealed that the mutation affected nucleotides 3245-3247, codon 1082, and changed the sequence from ATC to TGAT, inducing a stop codon downstream at codon 1095 and leading to early truncation of the ATM protein. Perpendicular DGGE (denaturing gradient gel electrophoresis) was used to screen 10 additional families for this mutation. The 3245 delATC insTGAT mutation was found in 12 of 22 proband alleles: five patients were homozygotes and two heterozygotes. Haplotype analyses were performed using eight microsatellite markers, within and flanking the ATM gene. All carriers of the mutation described were found to have a common haplotype of the five closest CA-repeat microsatellite markers. Genealogical investigations of the families identified a common ancestor for three of the families. The common ancestor was a woman born in 1684 in the area from which these families originate. The prevalence of this mutation in Norwegian patients now allows a major subset of AT heterozygotes to be identified, both in the general population and in breast cancer patients, so that their cancer risk can be evaluated.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 36 条
[1]   Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer [J].
Athma, P ;
Rappaport, R ;
Swift, M .
CANCER GENETICS AND CYTOGENETICS, 1996, 92 (02) :130-134
[2]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[3]   New mutations in the ataxia telangiectasia gene [J].
Baumer, A ;
Bernthaler, U ;
Wolz, W ;
Hoehn, H ;
Schindler, D .
HUMAN GENETICS, 1996, 98 (02) :246-249
[4]   AT-tributable risks? [J].
Bishop, DT ;
Hopper, J .
NATURE GENETICS, 1997, 15 (03) :226-226
[5]   BREAST-CANCER AND OTHER CANCERS IN NORWEGIAN FAMILIES WITH ATAXIA-TELANGIECTASIA [J].
BORRESEN, AL ;
ANDERSEN, TI ;
TRETLI, S ;
HEIBERG, A ;
MOLLER, P .
GENES CHROMOSOMES & CANCER, 1990, 2 (04) :339-340
[6]  
Borresen Anne-Lise, 1996, P267
[7]  
BUNDY S, 1994, INT J RAT BIOL S, pS23
[8]   Mutations revealed by sequencing the 5' half of the gene for ataxia telangiectasia [J].
Byrd, PJ ;
McConville, CM ;
Cooper, P ;
Parkhill, J ;
Stankovic, T ;
McGuire, GM ;
Thick, JA ;
Taylor, AMR .
HUMAN MOLECULAR GENETICS, 1996, 5 (01) :145-149
[9]   Heterozygous ATM mutations do not contribute to early onset of breast cancer [J].
FitzGerald, MG ;
Bean, JM ;
Hegde, SR ;
Unsal, H ;
MacDonald, DJ ;
Harkin, DP ;
Finkelstein, DM ;
Isselbacher, KJ ;
Haber, DA .
NATURE GENETICS, 1997, 15 (03) :307-310
[10]   LOCALIZATION OF AN ATAXIA-TELANGIECTASIA GENE TO CHROMOSOME 11Q22-23 [J].
GATTI, RA ;
BERKEL, I ;
BODER, E ;
BRAEDT, G ;
CHARMLEY, P ;
CONCANNON, P ;
ERSOY, F ;
FOROUD, T ;
JASPERS, NGJ ;
LANGE, K ;
LATHROP, GM ;
LEPPERT, M ;
NAKAMURA, Y ;
OCONNELL, P ;
PATERSON, M ;
SALSER, W ;
SANAL, O ;
SILVER, J ;
SPARKES, RS ;
SUSI, E ;
WEEKS, DE ;
WEI, S ;
WHITE, R ;
YODER, F .
NATURE, 1988, 336 (6199) :577-580